Javascript must be enabled to continue!
Rhinitis is associated with a greater risk of intermittent claudication in adults
View through CrossRef
AbstractBackgroundChronic inflammatory airway disorders have been reported to be associated with vascular diseases of the heart and central nervous system, but their association with peripheral arterial disease (PAD), a high‐prevalence vascular illness, has not been investigated.ObjectiveTo evaluate the association of asthma and rhinitis with intermittent claudication, which is a typical symptom of PAD.MethodsThe data were collected in the gene–environment interaction in respiratory disease survey, a population‐based, multicase–control study. Participants underwent a standardized interview, skin prick tests and pulmonary function tests. The associations between respiratory diseases and intermittent claudication (i.e. pain in the leg during walking that disappears within 10 min when standing still) were estimated through relative risk ratios (RRR) by multinomial logistic regression models.Results1174 subjects (aged 20–64 years, of which 52% were females) underwent clinical examinations and were classified into four groups: asthma only (n = 81), asthma–rhinitis overlap (n = 292), rhinitis only (n = 299) and controls (n = 345). The prevalence of intermittent claudication in these groups was, respectively, 2.5%, 3.4%, 6.4% and 2.3%. After adjusting for smoking habits and a wide range of established and potential vascular risk factors, rhinitis without asthma was associated with intermittent claudication (RRR:4.63, 95% CI:1.72–12.5), whereas no significant association was found with asthma alone (RRR:1.45, 95% CI:0.27–7.76) or asthma–rhinitis overlap (RRR:2.89, 95% CI:0.91–9.18). Atopy did not modify the observed association between intermittent claudication and rhinitis.ConclusionsOur findings suggest that rhinitis is associated with PAD, a predictor of future cerebrovascular and cardiovascular events, independently of the presence of atopy.
Title: Rhinitis is associated with a greater risk of intermittent claudication in adults
Description:
AbstractBackgroundChronic inflammatory airway disorders have been reported to be associated with vascular diseases of the heart and central nervous system, but their association with peripheral arterial disease (PAD), a high‐prevalence vascular illness, has not been investigated.
ObjectiveTo evaluate the association of asthma and rhinitis with intermittent claudication, which is a typical symptom of PAD.
MethodsThe data were collected in the gene–environment interaction in respiratory disease survey, a population‐based, multicase–control study.
Participants underwent a standardized interview, skin prick tests and pulmonary function tests.
The associations between respiratory diseases and intermittent claudication (i.
e.
pain in the leg during walking that disappears within 10 min when standing still) were estimated through relative risk ratios (RRR) by multinomial logistic regression models.
Results1174 subjects (aged 20–64 years, of which 52% were females) underwent clinical examinations and were classified into four groups: asthma only (n = 81), asthma–rhinitis overlap (n = 292), rhinitis only (n = 299) and controls (n = 345).
The prevalence of intermittent claudication in these groups was, respectively, 2.
5%, 3.
4%, 6.
4% and 2.
3%.
After adjusting for smoking habits and a wide range of established and potential vascular risk factors, rhinitis without asthma was associated with intermittent claudication (RRR:4.
63, 95% CI:1.
72–12.
5), whereas no significant association was found with asthma alone (RRR:1.
45, 95% CI:0.
27–7.
76) or asthma–rhinitis overlap (RRR:2.
89, 95% CI:0.
91–9.
18).
Atopy did not modify the observed association between intermittent claudication and rhinitis.
ConclusionsOur findings suggest that rhinitis is associated with PAD, a predictor of future cerebrovascular and cardiovascular events, independently of the presence of atopy.
Related Results
Intermittent claudication among smokers
Intermittent claudication among smokers
Introduction: Peripheral artery disease with intermittent claudication is an important cause of morbidity and mortality. Cigarette smoking is thought to be major risk factor. Curre...
Intermittent claudication among smokers
Intermittent claudication among smokers
Introduction: Peripheral artery disease with intermittent claudication is an important cause of morbidity and mortality. Cigarette smoking is thought to be major risk factor. Curre...
Rhinitis-Respect your nose
Rhinitis-Respect your nose
We all know the functions of nose i.e. breathing and smell. The outcome of breathing is to ventilate the lungs and we also know that there is lung compliance which reflects its eff...
Persistent rhinitis – allergic or nonallergic?
Persistent rhinitis – allergic or nonallergic?
SummaryAlthough rhinitis has been classified as being either allergic, noninfectious, or ‘‘other forms’’ (nonallergic noninfectious), these categories lack strict classification cr...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Lipoprotein(a) as an independent factor associated with intermittent claudication
Lipoprotein(a) as an independent factor associated with intermittent claudication
Objective. To evaluate the relationship between lipoprotein(a) [Lp(a)], apoprotein(a) phenotypes, and inflammatory markers depending on symptoms of lower extremity artery atheroscl...
Prevalence and Contributing Factors of Rhinitis Among a Sample of Medical Students in Baghdad
Prevalence and Contributing Factors of Rhinitis Among a Sample of Medical Students in Baghdad
Background: Rhinitis and nasal irritation are highly prevalent, significantly impacting the quality of life for millions of patients. The high prevalence of rhinitis in Iraq may be...
Cilostazol: Treatment of Intermittent Claudication
Cilostazol: Treatment of Intermittent Claudication
OBJECTIVE:
To review the pharmacology and clinical utility of cilostazol, an antiplatelet and vasodilator agent approved for the management of intermittent clau...

